These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 2933460)
1. Differences in "host infiltrates" among lymphoma patients treated with anti-idiotype antibodies: correlation with treatment response. Garcia CF; Lowder J; Meeker TC; Bindl J; Levy R; Warnke RA J Immunol; 1985 Dec; 135(6):4252-60. PubMed ID: 2933460 [TBL] [Abstract][Full Text] [Related]
2. The generation of monoclonal anti-idiotype antibodies to human B cell-derived leukemias and lymphomas. Giardina SL; Schroff RW; Kipps TJ; Woodhouse CS; Abrams PG; Rager HC; Morgan AC; Foon KA J Immunol; 1985 Jul; 135(1):653-8. PubMed ID: 3873497 [TBL] [Abstract][Full Text] [Related]
3. Idiotype-specific helper cells (BH) express immunoglobulin markers and employ T cell function-associated molecules. Sherr DH; Ju ST J Immunol; 1986 Dec; 137(11):3406-13. PubMed ID: 2946760 [TBL] [Abstract][Full Text] [Related]
4. Direct receptor:receptor interactions between T and B lymphocytes: idiotypic restriction in the antibody response to a cloned helper T cell receptor. Janeway CA; Broughton B; Smith LA; Marion TN; Bottomly K J Mol Cell Immunol; 1987; 3(2):83-94. PubMed ID: 2978239 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody therapy of lymphoid malignancy. Lowder JN; Meeker TC; Levy R Cancer Surv; 1985; 4(2):359-75. PubMed ID: 3842318 [TBL] [Abstract][Full Text] [Related]
6. The use of a monoclonal anti-idiotype antibody to study the biology of a human B cell lymphoma. Hatzubai A; Maloney DG; Levy R J Immunol; 1981 Jun; 126(6):2397-402. PubMed ID: 6785351 [TBL] [Abstract][Full Text] [Related]
7. Tumor-specific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2 beta). Raychaudhuri S; Saeki Y; Chen JJ; Iribe H; Fuji H; Kohler H J Immunol; 1987 Jul; 139(1):271-8. PubMed ID: 2953815 [TBL] [Abstract][Full Text] [Related]
8. Synergistic antitumor activity with IFN and monoclonal anti-idiotype for murine B cell lymphoma. Mechanism of action. Basham TY; Race ER; Campbell MJ; Reid TR; Levy R; Merigan TC J Immunol; 1988 Oct; 141(8):2855-60. PubMed ID: 2971732 [TBL] [Abstract][Full Text] [Related]
9. Anti-idiotypes in B-cell tumor therapy. Miller RA; Lowder J; Meeker TC; Brown S; Levy R NCI Monogr; 1987; (3):131-4. PubMed ID: 3493440 [TBL] [Abstract][Full Text] [Related]
10. Immunohistologic localization and immune phenotypes of lymphocytes expressing Tac antigen in human lymphoid tissues. Miyawaki T; Ohzeki S; Ikuta N; Seki H; Taga K; Taniguchi N J Immunol; 1984 Dec; 133(6):2996-3000. PubMed ID: 6092463 [TBL] [Abstract][Full Text] [Related]
11. Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen. Foon KA; Oseroff AR; Vaickus L; Greenberg SJ; Russell D; Bernstein Z; Pincus S; Köhler H; Seon BK; Tahaoglu E Clin Cancer Res; 1995 Nov; 1(11):1285-94. PubMed ID: 9815923 [TBL] [Abstract][Full Text] [Related]
12. Sporadic idiotypic cross-reactivities between antibodies and T helper cells: one example of aleatory expression of T cell idiotypes. Martinez C; Coutinho A; Bandeira A; de la Hera A; Toribio M; Marcos MA; Pereira P J Mol Cell Immunol; 1987; 3(1):21-8. PubMed ID: 2978237 [TBL] [Abstract][Full Text] [Related]
13. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. Via CS; Sharrow SO; Shearer GM J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440 [TBL] [Abstract][Full Text] [Related]
14. Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression. Tedder TF; Clement LT; Cooper MD J Immunol; 1985 May; 134(5):2983-8. PubMed ID: 3156922 [TBL] [Abstract][Full Text] [Related]
15. The use of monoclonal antibodies in the diagnosis of peripheral T-cell lymphomas. Giraldo AA; Higgins MJ; Zielinska E; Humes JJ Ann Clin Lab Sci; 1987; 17(2):67-73. PubMed ID: 2953297 [TBL] [Abstract][Full Text] [Related]
16. B-cell transplants to immunodeficient xid neonates do not imprint their helper T cells. Quintans J; Wemhoff GA J Mol Cell Immunol; 1988; 4(2):97-103. PubMed ID: 2978376 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody]. Kon S Gan To Kagaku Ryoho; 1988 May; 15(5):1685-92. PubMed ID: 3259417 [TBL] [Abstract][Full Text] [Related]
18. Induction of T cell-dependent B cell differentiation by anti-CD3 monoclonal antibodies. Stohl W; Posnett DN; Chiorazzi N J Immunol; 1987 Mar; 138(6):1667-73. PubMed ID: 2950165 [TBL] [Abstract][Full Text] [Related]
19. T cell development in B cell deficient mice. III. Restriction specificity of suppressor T cell factor(s) produced in mice treated chronically with rabbit anti-mouse mu chain antibody. HayGlass KT; Naides SJ; Benacerraf B; Sy MS J Mol Cell Immunol; 1985; 2(2):107-17. PubMed ID: 2978459 [TBL] [Abstract][Full Text] [Related]
20. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants. Kaminski MS; Kitamura K; Maloney DG; Campbell MJ; Levy R J Immunol; 1986 Feb; 136(3):1123-30. PubMed ID: 3484499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]